GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 81 filers reported holding GLYCOMIMETICS INC in Q4 2017. The put-call ratio across all filers is 2.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,000 | -83.3% | 2,319 | +16.0% | 0.00% | – |
Q1 2024 | $6,000 | – | 2,000 | +1097.6% | 0.00% | – |
Q2 2023 | $0 | -100.0% | 167 | -91.6% | 0.00% | – |
Q4 2022 | $6,000 | – | 2,000 | +900.0% | 0.00% | – |
Q3 2022 | $0 | -100.0% | 200 | -93.3% | 0.00% | – |
Q2 2021 | $7,000 | -36.4% | 2,997 | -14.7% | 0.00% | – |
Q1 2021 | $11,000 | +10.0% | 3,515 | +27.1% | 0.00% | – |
Q4 2020 | $10,000 | – | 2,766 | +13730.0% | 0.00% | – |
Q3 2020 | $0 | – | 20 | -84.1% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 126 | -40.6% | 0.00% | – |
Q4 2019 | $1,000 | -92.3% | 212 | -75.7% | 0.00% | – |
Q3 2018 | $13,000 | – | 873 | +9600.0% | 0.00% | – |
Q3 2017 | $0 | -100.0% | 9 | -98.2% | 0.00% | – |
Q1 2017 | $3,000 | -25.0% | 488 | -28.8% | 0.00% | – |
Q4 2016 | $4,000 | +300.0% | 685 | +825.7% | 0.00% | – |
Q4 2014 | $1,000 | 0.0% | 74 | 0.0% | 0.00% | – |
Q3 2014 | $1,000 | 0.0% | 74 | 0.0% | 0.00% | – |
Q2 2014 | $1,000 | – | 74 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 7,361,801 | $38,944,000 | 2.95% |
NEA Management Company, LLC | 9,089,041 | $48,081,000 | 2.27% |
Camber Capital Management LP | 3,500,000 | $18,515,000 | 0.94% |
Redmile Group, LLC | 1,343,845 | $7,109,000 | 0.17% |
CAXTON CORP | 25,748 | $136,000 | 0.13% |
Alambic Investment Management, L.P. | 15,210 | $80,000 | 0.07% |
Virtus ETF Advisers LLC | 69,120 | $366,000 | 0.06% |
OXFORD ASSET MANAGEMENT LLP | 133,008 | $704,000 | 0.02% |
AXA S.A. | 1,890,492 | $10,002,000 | 0.02% |
Athanor Capital, LP | 59,572 | $315,000 | 0.01% |